Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares, Euro 0.09 nominal value per share
-
Shares outstanding
-
75.9M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
22.2M
-
Shares change
-
-4.62M
-
Total reported value, excl. options
-
$488M
-
Value change
-
-$93.8M
-
Number of buys
-
28
-
Number of sells
-
-34
-
Price
-
$22.00
Significant Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) as of Q3 2021
77 filings reported holding MRUS - Merus N.V. - Common Shares, Euro 0.09 nominal value per share as of Q3 2021.
Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.2M shares
of 75.9M outstanding shares and own 29.21% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (5.01M shares), FEDERATED HERMES, INC. (2.93M shares), BAKER BROS. ADVISORS LP (2.04M shares), BOXER CAPITAL, LLC (1.9M shares), Medicxi Ventures Management (Jersey) Ltd (1.6M shares), BioImpact Capital LLC (942K shares), COMMODORE CAPITAL LP (718K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (669K shares), MILLENNIUM MANAGEMENT LLC (557K shares), and Avoro Capital Advisors LLC (450K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.